September 18, 2018
September 18, 2018
PHILADELPHIA – (BUSINESS WIRE) – Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage […]
June 1, 2018
June 1, 2018
PHILADELPHIA – (BUSINESS WIRE) -Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, celebrates a milestone of mapping 1,000 epitopes […]
May 30, 2018
May 30, 2018
Integral Molecular, the industry leader in membrane protein antibody discovery, announces the development of antibody assets targeting membrane proteins important in oncology (Claudin 6) and metabolic […]
March 13, 2018
March 13, 2018
PHILADELPHIA – (BUSINESS WIRE) -Integral Molecular, the industry leader in engineering membrane proteins, has extended its protein engineering capabilities to stabilize viral proteins and produce more […]
December 21, 2017
December 21, 2017
PHILADELPHIA–(BUSINESS WIRE)– Integral Molecular, the industry leader in the expression and characterization of multipass membrane proteins, has expanded its mapping capabilities to include small molecules. This […]
September 6, 2017
September 6, 2017
PHILADELPHIA (September 6, 2017) – A new kind of interdisciplinary artistic collaboration is happening in Philadelphia this fall. The University City Science Center has partnered with […]
August 30, 2017
August 30, 2017
PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a Philadelphia based biotechnology company, announces the expansion of its facility, personnel, and resources dedicated to antibody discovery for membrane protein targets. The […]
June 15, 2017
June 15, 2017
PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein technologies, has initiated a therapeutic target discovery program in immuno-oncology by exploiting its Membrane Proteome Array technology to […]
June 7, 2017
June 7, 2017
PHILADELPHIA–Integral Molecular announces the expansion of its proprietary Membrane Proteome Array™ to now consist of 5,300 unique human membrane proteins, representing nearly the entire human membrane […]
May 18, 2017
May 18, 2017
ROCKVILLE, Md., May 18, 2017 /PRNewswire/ — In research published online today in Cell, a team of scientists describe an antibody called CA45, elicited by immunization […]
March 2, 2017
March 2, 2017
Integral Molecular and Integrated BioTherapeutics Initiate Collaboration for Virus Vaccine Discovery
Philadelphia, PA & Rockville, MD. (BUSINESSWIRE) March 2, 2017 —Integral Molecular and Integrated BioTherapeutics have teamed up in the fight against the global health crises posed […]
November 16, 2016
November 16, 2016
Integral Molecular isolates Zika-specific monoclonal antibodies for vaccine research and diagnostics
PHILADELPHIA — Integral Molecular announces the isolation of neutralizing monoclonal antibodies specific for the Zika virus envelope, thereby enabling vital vaccine research and the development of […]
November 7, 2016
November 7, 2016
Administering a human antibody that neutralizes Zika virus to pregnant mice before or after Zika virus infection reduced levels of the virus in placental and fetal […]
September 21, 2016
September 21, 2016
Integral Molecular announces the launch of the Membrane Proteome Array™ (MPA), a rapid and reliable platform for de-risking therapeutic development by profiling the target specificity of […]
August 25, 2016
August 25, 2016
Philadelphia, PA–(BUSINESS WIRE)–Integral Molecular, an industry leader in membrane protein antibody discovery, has announced a major advancement in understanding the functionality of G protein-coupled receptors (GPCRs), […]
May 26, 2016
May 26, 2016
Integral Molecular, a leader in antibody discovery, announces the development of an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune […]
February 10, 2016
February 10, 2016
Integral Molecular, a leader in membrane protein antibody discovery, has announced the issuance of two key patents in Europe and the U.S., strengthening the company’s rapidly […]
December 11, 2015
December 11, 2015
Integral Molecular, a leader in membrane protein antibody discovery, announced today the appointment of DNA immunization expert Ross Chambers, Ph.D., as Director of Antibody Discovery. Dr. […]
November 12, 2015
November 12, 2015
To support the creation of Ebola virus vaccines and treatments, Integral Molecular, a leader in membrane protein antibody discovery, has identified the key molecular interactions that […]
October 15, 2015
October 15, 2015
With a new $5.5M award from the National Institute of Allergy and Infectious Diseases (NIAID) part of the National Institutes of Health (NIH), Integral Molecular, Inc. […]